| Melissa M Go, MD | |
|
337 E Coronado Rd, Suite 201, Phoenix, AZ 85004-1580 | |
| (602) 252-8081 | |
| (602) 252-1520 |
| Full Name | Melissa M Go |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 31 Years |
| Location | 337 E Coronado Rd, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053305540 | NPI | - | NPPES |
| 476954 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 27696 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwest Kidney/davita-phoenix Home Dialysis (dva) | Phoenix, AZ | Dialysis facility |
| Southwest Kidney Dialysis - Arrowhead Lakes (dva) | Glendale, AZ | Dialysis facility |
| St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
| Banner - University Medical Center Phoenix | Phoenix, AZ | Hospital |
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Abrazo Central Campus | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Kidney Institute Plc | 8224930987 | 81 |
News Archive
A potential life-saving treatment for severe E. coli food poisoning outbreaks - developed more than a decade ago - hasn't gone forward into clinical trials because of lack of commercial interest.
The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.
A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
Compli, the nation's leading provider of HR and compliance management software, is proud to announce a strategic alliance with Wallace Welch & Willingham, a leading privately held insurance agency with more than 85 years of experience.
› Verified 1 days ago
| Entity Name | Southwest Kidney Institute Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659316008 PECOS PAC ID: 8224930987 Enrollment ID: O20040211001069 |
News Archive
A potential life-saving treatment for severe E. coli food poisoning outbreaks - developed more than a decade ago - hasn't gone forward into clinical trials because of lack of commercial interest.
The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.
A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
Compli, the nation's leading provider of HR and compliance management software, is proud to announce a strategic alliance with Wallace Welch & Willingham, a leading privately held insurance agency with more than 85 years of experience.
› Verified 1 days ago
| Entity Name | Southwest Kidney Institute Scottsdale Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902231012 PECOS PAC ID: 3577798313 Enrollment ID: O20131101000457 |
News Archive
A potential life-saving treatment for severe E. coli food poisoning outbreaks - developed more than a decade ago - hasn't gone forward into clinical trials because of lack of commercial interest.
The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.
A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
Compli, the nation's leading provider of HR and compliance management software, is proud to announce a strategic alliance with Wallace Welch & Willingham, a leading privately held insurance agency with more than 85 years of experience.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa M Go, MD 2149 E Warner Rd, Suite 101, Tempe, AZ 85284-3494 Ph: (480) 610-6100 | Melissa M Go, MD 337 E Coronado Rd, Suite 201, Phoenix, AZ 85004-1580 Ph: (602) 252-8081 |
News Archive
A potential life-saving treatment for severe E. coli food poisoning outbreaks - developed more than a decade ago - hasn't gone forward into clinical trials because of lack of commercial interest.
The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.
A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
Compli, the nation's leading provider of HR and compliance management software, is proud to announce a strategic alliance with Wallace Welch & Willingham, a leading privately held insurance agency with more than 85 years of experience.
› Verified 1 days ago
Moustafa I Hazin, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165 | |
Dr. Ali Shaheen Al-yaqoobi, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411 | |
Dana Archbold, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084 | |
Catalina Nicole Flores, MD Nephrology Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000 | |
Kristina Yancey, Nephrology Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000 | |
Dr. Francisco Cordova, MD Nephrology Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971 | |
Dr. Dimpy Kapoor, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013 |